Literature DB >> 7730844

Estimation of CHD risk in a French working population using a modified Framingham model. The PCV-METRA Group.

D Laurier1, P C Nguyen, B Cazelles, P Segond.   

Abstract

We adapt a recent model from the Framingham study (Circulation 1991; 83: 356-362) to predict CHD in France for both sexes over a large age range. Calculations were based on data from the French PCV-METRA study. In France, the Paris Prospective Study model could predict CHD but only for men aged 43-53 years. Applied to men 43-53 years from the PCV-METRA, the Framingham model estimated a 5-year CHD risk (4%) lower than the risk reported in the Framingham sample, but significantly higher than the risk estimated by the French model (2%). Differences in estimated CHD risk between the Framingham and the PCV-METRA samples were explained for only 30% by adjustment on major CHD risk factors (mainly HDL-cholesterol and tobacco). Modifying the intercept in the Framingham model, agreement with estimated risk by the French model was improved from 29 to 80%. By an appropriate change of the intercept, the Framingham model might be used to estimate CHD risk in other populations.

Entities:  

Mesh:

Year:  1994        PMID: 7730844     DOI: 10.1016/0895-4356(94)90079-5

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  19 in total

1.  Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men.

Authors:  I U Haq; L E Ramsay; W W Yeo; P R Jackson; E J Wallis
Journal:  Heart       Date:  1999-01       Impact factor: 5.994

Review 2.  What is the ideal blood pressure goal for patients with stage III or higher chronic kidney disease?

Authors:  Yazan Khouri; Susan P Steigerwalt; Mershed Alsamara; Peter A McCullough
Journal:  Curr Cardiol Rep       Date:  2011-12       Impact factor: 2.931

3.  Relationship between ankle brachial index and arterial remodeling in pseudoxanthoma elasticum.

Authors:  Georges Lefthériotis; Pierre Abraham; Yannick Le Corre; Olivier Le Saux; Daniel Henrion; Pierre Henri Ducluzeau; Fabrice Prunier; Ludovic Martin
Journal:  J Vasc Surg       Date:  2011-07-01       Impact factor: 4.268

4.  Validation of the pneumonia severity index. Importance of study-specific recalibration.

Authors:  W D Flanders; G Tucker; A Krishnadasan; D Martin; E Honig; W M McClellan
Journal:  J Gen Intern Med       Date:  1999-06       Impact factor: 5.128

5.  Comparison of cardiovascular risk profile between male employees of two automotives companies in France and Sweden. The Coeur Project Group.

Authors:  A Simon; L Dimberg; J Levenson; C Lanoiselée; M Massonneau; B Eriksson; S Jern; L Kumlin; P Marin; B Dahlöf; L Hansson; P Björntorp
Journal:  Eur J Epidemiol       Date:  1997-12       Impact factor: 8.082

6.  Outcome of coronary plaque burden: a 10-year follow-up of aggressive medical management.

Authors:  Victor K Goh; Chu-Pak Lau; Stefan Mohlenkamp; John A Rumberger; Stephan Achenbach; Matthew J Budoff
Journal:  Cardiovasc Ultrasound       Date:  2010-03-12       Impact factor: 2.062

7.  Disease prevention--should we target obesity or sedentary lifestyle?

Authors:  Olivier L Charansonney; Jean-Pierre Després
Journal:  Nat Rev Cardiol       Date:  2010-05-25       Impact factor: 32.419

8.  Cardiovascular risk prediction tools for populations in Asia.

Authors:  F Barzi; A Patel; D Gu; P Sritara; T H Lam; A Rodgers; M Woodward
Journal:  J Epidemiol Community Health       Date:  2007-02       Impact factor: 3.710

9.  Prediction of mortality from coronary heart disease among diverse populations: is there a common predictive function?

Authors: 
Journal:  Heart       Date:  2002-09       Impact factor: 5.994

10.  Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study.

Authors:  Peter Brindle; Jonathan Emberson; Fiona Lampe; Mary Walker; Peter Whincup; Tom Fahey; Shah Ebrahim
Journal:  BMJ       Date:  2003-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.